This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Vera-Llonch M, Massarotti E, Wolfe F, Shadick N, Westhovens R, Sofrygin O, Maclean R, Li T, Oster G.Cost-effectiveness of abatacept in patients with moderately to severely active rheumatoid arthritis and inadequate response to tumor necrosis factor-alpha antagonists. The Journal of Rheumatology 35: 1745-1753, No. 9, Sep 2008
Rights and permissions
About this article
Cite this article
Cost effectiveness of costimulation modulator in anti-TNF-resistant RA. Pharmacoecon. Outcomes News 564, 8 (2008). https://doi.org/10.2165/00151234-200805640-00018
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200805640-00018